Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imipenem. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101921275B reveals a streamlined Imipenem manufacturing route featuring solvent clathrate technology, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced synthesis of Imipenem monohydrate via phosphorylation and condensation. Reduces impurities and enhances yield for reliable pharmaceutical intermediates supply.
Patent CN101921274A reveals a streamlined Imipenem synthesis using solvent inclusion intermediates, offering significant cost reduction and high-purity manufacturing for pharmaceutical supply chains.
Patent CN112142740B reveals a novel buffer-based purification method for Imipenem, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101973915A details a cost-effective synthesis of carbapenem intermediate 4-BMA using a recoverable chiral sulfonamide auxiliary for improved stereoselectivity.
Novel patent CN108623598A details improved Imipenem synthesis reducing impurities and enhancing crystallinity for reliable pharmaceutical intermediate supply chains.